Medical research highlights, May 2025 | Newsroom

The UNMC College of Medicine recently received grants and awards for new funds of 4.4 million US dollars. Awards included:

• Siddappa Byrareddy, PhD, Pharmacology and experimental neurosciences received a grant of $ 844,946 from the DHHS/NIH/Nida in order to investigate cannabinoid inhibition of activating CNS inflammasome by modulating the intestinal shine.
• Howard Gendelman, MD, Pharmacology and experimental neurosciences received a grant of $ 736,036 from the DHHS/NIH/NIMH to examine targeted lipid nanoparticles for the approach of the Gen therapeutic agents to exterminate HIV reservoirs.
• Shilpa Buch, PhD, Pharmacology and experimental neurosciences received a subsidy of $ 441,154 from the DHHS/NIH/NIH/NIH for the study “Molecular interplay of HIV -Tat, cocaine and carts in microglia pyroptic: Role of the NLRP3 inflammasome.”
• Russell McCulloh, MD, Pädiatrie Hospital received from the University of Kansas Medical Center for the implementation of the new guidelines for pediatric obesity in rural families and clinics: a randomized clinical study.
• Joshua Bies, Md, Pediatric hematology/oncology received a scholarship of 27,026 USD from the pediatric blood and mark transplantation consortium for an attempt with low and moderate exposure buses for infants with severe combined immunodeficiency (SCID), the TCRASS+/CD19+ Depleted Transplantante.
• Roslyn Mannon, Md, Internal Medicine-Nephrology received a scholarship of $ 2,766 from the Hennepin Healthcare Research Institute for Staffing.
• Angela Yetman, MD, Pädiatrie cardiology received a scholarship of $ 700 from the longitudinal formation of the longitudinal formation for the aortic imaging for the aortic formation of the longitudinal. “

Industry -shaped grants and contracts:

The following grants and contracts sponsored by the industry were received.

• Mara Seier, Md, Neurological sciences received funding for participants with several system atrophy for an attempt with LU AF82422.
• Ronald Zolty, MD, PhD, Inner medical-cardiovascular, received funds to assess the effectiveness and security of TX000045 after 24 weeks of treatment in patients with pulmonary hypertension secondary to heart failure with preserved ejection fractions; and financing to assess the security and effectiveness of vutrisisiran in patients with trometinamyloidosis with cardiomyopathy.
• Kelsey Klute, Md, Internal medical oncology/hematology received a financing for a study with quemliustat and chemotherapy compared to placebo and chemotherapy in patients with treatment-naive metastatic pancreatic duka care.
• Rana Zabad, MD, Neurological sciences received funds to evaluate the security and clinical activity of AzerCabtagen-Zapreleucel for participants with B-cell-mediated autoimmune diseases.
• Jason Payne, Md, Internal Medicine cardiovascular has received funds for “Pult AF study after the assumption that an addendum to the pulsed PfA-global register”.
• Bhavina Sharma, MD, Internal medical oncology/hematology received funds for a study with inhalative KB707 in patients with advanced solid tumor malignatures that affect the lungs.
• Hani Haider, PhD, Orthopedic surgery, financing for one in vitro Wear the durability study of the Maxx orthopedics -Unicondylar knee replacement.